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Summary The nature of neoplasia and its sometime end result, cancer, has been studied by exposition and
explanation of the sequential lesions of tumour progression. Neoplastic lesions were divided into four classes
on the basis of growth characterisitcs and whether lesional growth is confined to one or more tissue
compartments. Class IA, the initial lesion, an orderly, probably clonal growth, usually differentiates and
disappears. Class IB: Failure to differentiate accompanied by disorderly growth. Class IC: Randomly dispersed
atypical cells, constituting a precursor state. Class II, intermediate lesions, apparently arising from the atypical
cells, show temporally unrestricted growth within the tissue compartment of origin. Class III lesions, primary
invasive cancers, show temporally unrestricted growth in two or more tissue compartments and metastasise
along different paths, a property associated with extracellular matrix interaction. The metastatic pathways may
result from different subsets of cells in the primary cancer. Class IV lesions are the metastases. It was
concluded that, all neoplasms develop in the same way, have the same general behavioural characteristics, and,
when malignant, all interact with the extracellular matrix of the primary and the secondary sites. The origins
and development of cancer are considered to be pluralistic and not due to a discrete change in a cell, whose
progeny, as a result of that discrete change, carries all of the information required to explain the almost
limitless events of a neoplastic system.
The induction of a neoplastic system does not result in
cancer as the initial lesion, with rare exceptions. At the
outset, the lesions produced by carcinogens are not cancer
but focal proliferations that are orderly in form and tem-
porally restricted in their growth; benign tumours in classical
nosology. If other lesions, with abnormal form and cytology
as compared with the initial lesion, are to appear they follow
the initial lesion. If a lesion with the biological properties of
primary cancer is to appear, it usually does so only after at
least one half of the life span of the affected subject has
passed. The sequential lesional events between induction and
cancer, including metastases, may be encompassed by the
term tumour progression; the subject of this paper. The
development of cancer seems to be similar, though not
precisely identical, in all neoplastic systems. The concepts
presented are based upon the personal study, over a period
of some 25 years, of all of the sequential lesions of human
melanocytic neoplasia and a comparison of the observed
phenomena with some other forms of neoplasia. What I have
attempted to do is to describe the classes of lesions seen in
neoplatic development based upon the behaviour (life his-
tory) of the various lesions. Next, I have presented, without
explanation, the lesional classes as illustrated by human
melanocytic neoplasia. These classes are then compared with
other neoplastic systems. Finally, I have attempted explana-
tion and formulation of a conceptual framework for the
nature of cancer based upon these observations of cancer
development. The conclusions derived about the nature of
cancer are pluralistic and are not considered as due to some
discrete change in a cell, whose progeny, as a result of that
discrete change, carries all of the information required to
explain the almost limitless events of a neoplastic system.
The Pigmented Lesion Study Group of the University of
Pennsylvania has studied tumour progression in melanocytic
neoplasia since 1 September 1972. We have studied 2,383
patients with melanoma through 31 December 1990. For
each patient, 343 clinical and pathology attributes have been
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recorded and computerised. Features such as the number and
kinds of melanocytic nevi and the detailed pathology of the
primary melanomas have been investigated. We have follow-
ed our patients prospectively and <2% have been lost to
follow-up. Such follow-up has permitted us to document the
behaviour and biologic significance of the various lesions of
tumour progression. Details of the methodology have been
previously published (Clark et al., 1984, 1989). We have
photographed the entire skin of all patients since 1 May
1976. The presence of pigmented lesions, affording excellent
visibility, on the body surface makes it possible to document
the macroscopic events (and their microscopic corollaries) of
tumour progression in this paradigmatic neoplastic system.
In no other neoplastic system, human or experimental, is this
so readily accomplished. Perhaps, in no other system is this
possible. Here, the results of our studies are compared with
experimental hepatocarcinogenesis and cutaneous carcino-
genesis, as well as with human keratinocytic and colonic
neoplasia. Other neoplastic systems, carcinoma of the cervix,
for instance, are apparently similar. The correspondencies
between the different neoplastic systems suggest the unifying
hypothesis that tumour progression is the dominant biologic
phenomenon linking the diverse kinds of neoplasia into a
single disease entity.
Definitions
The lack of understanding of the basic biology of neoplasia
has resulted in different definitions of even its most funda-
mental terms. The following definitions permit the reader to
understand how we use terms essential to discussions of
neoplastic biology (Clark, 1991).
Cancer is a population of abnormal cells showing tem-
porally unrestricted growth preference (continually increas-
ing numbers of cells in the population) over their normal
counterparts. Such abnormal cells invade surrounding tis-
sues, traverse at least one basement membrane zone, grow
in the mesenchyme at the primary site, and may metasta-
sise to distant sites. It is the totality of properties, not any
one property, that determines whether or not a given
lesion should be designated as a cancer. The fully evolved
cancer is a population of abnormal cells showing tempor-
ally unrestricted growth preference over the surrounding
cells and the ability to grow in a least three different tissue
compartments: the original compartment, the mesenchyme
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of the primary site; and a distant mesenchyme. A cancer of
hematopoietic or lymphoid cell origin also shows tempor-
ally unrestricted growth over its normal counterparts.
These cancers, when fully evolved, commonly extend into
many tissue compartments, for the ability to transverse an
endothelial basement membrane zone is a part of the
parent cell's phenotype, not a property necessarily acquir-
ed during neoplastic evolution.
Neoplasia is all focal proliferative lesions, benign tumours,
primary cancers, and metastases, that may affect any given
cell system. Where studied, the beginnings of neoplasia
have been clonal.
Tumour progression designates a sequence of focal changes
occurring within the proliferative lesions of a neoplastic
system resulting in a series of qualitatively different lesions;
lesions that may progress from benign to malignant to
increasing malignancy. Viewed as a process, tumour pro-
gression is not obligatory. Indeed, the net directionality of
lesions early in a tumour progression system is toward
regression.
Dysplasia is a focal proliferation of cells with temporally
restricted growth that shows an abnormal organisation of
tissue (aberrant differentation) and randomly scattered
cells with some of the features (cytologic atypia) of cells
seen in primary cancer. Both features should be observed
before the term dysplasia is used.
The classes of neoplastic lesions
The sequential lesions of neoplasia may be readily divided
into classes on the basis of growth characteristics, temporally
restricted (not autonomous) or temporally unrestricted (auto-
nomous or semi-autonomous), and whether lesional growth if
confined to a single tissue compartment or involves two or
more tissue compartments.!
Class I. The precursor lesions
The growth of these lesions is temporally restricted and
confined to the tissue compartment of origin. Initially, the
lesions show preferential growth over the surrounding tissue,
but growth ceases.
Class IA. The initial lesion The lesions are composed of an
organised collection of neoplastic parenchymal cells assoc-
iated with a histologically altered mesenchyme. The squa-
mous papilloma, induced by a carcinogen in the mouse skin,
is a prototype of an initial lesion. The lesions are biologically
benign and are clonal in systems that have been studied
(Burns, 1989). Of paramount interest, is the tendency for
initial lesions to disappear by a programmed pathway of
differentiation. If cancer is to develop in a neoplastic system,
an indication of this possibility is the failure of an initial
lesion to disappear. Initial lesions are numerous in most
neoplastic systems and progression to the next lesional class,
Class II, is quite rare. In addition to squamous papillomas,
common acquired melanocytic nevi (ordinary moles), adeno-
matous colonic polyps (tubular adenomas), and hepatocyte
nodules are examples of initial lesions. It may well be that
the lesions designated and described in this paper as initial
*It is unlikely that any lesion of neoplasia is ever truly autonomous.
Consequently, the terminology of temporally restricted ... growth
ceases after a time ..., or temporally unrestricted ... growth does
not cease ... is preferred. A tissue compartment is composed of an
organised collection of one or more cellular phenotypes separated
from other tissues by a basement membrane zone. Most tissue
compartments are composed of a single cellular phenotype, as in the
epithelium of the urinary bladder or the uterine exocervix. The
human epidermis is an exception. During intrauterine life, three
kinds of cells migrate into the keratinocytic epidermis: melanocytes,
Langerhan's cells, and Merkel cells.
lesions are physiological and protective. Such lesions have
been designated by Emmanuel Farber as 'clonal adaptation'.
This concept is covered in the summary and discussion of
this paper.
Class IB. Aberrant differentiation in the initial lesion Any
lesion that fails to follow the programmed pathway of deve-
lopment, evolution, and disappearance via differentiation
demonstrates aberrant differentiation, by definition. Such
failure is usually accompanied by disorganisation of growth
and cytologic abnormalities in the initial lesions or, less
commonly, is only manifested by persistence of the initial
lesion, rather than its disappearance. The form and behav-
iour of the initial lesion is the frame of reference for recogni-
tion and definition of the subsequent different types of Class
I lesions. It should be emphasised that all lesions of a tumour
progression series emerge focally in a preceding lesion. At the
outset, the new lesion does not globally replace its predeces-
sor. When tumour progression has reached Class IB, the
lesional mesenchyme is noticeably different from the normal
in routine histologic preparations. Such lesions may be stated
to have both a neoplastic parenchyma and a neoplastic
mesenchyme. Regression of Class IB lesions is seen and is
similar to that seen in initial lesions, but most Class IB
lesions are indolent. Progression to Class IC is uncommon.
Prototypic lesions include: (1) Melanocytic nevi with focal
abnormalities in the architecture of intraepidermal melano-
cytes (such as bridging of melanocytes from one rete to the
next) when compared with the pattern of intraepidermal
melanocytes in the initial lesion. (2) Persistent hepatocyte
nodules with spontaneous proliferation of a subset of cells.
(3) Squamous papillomas that do not regress and show
mitotic activity above the basal layer. (4) Small persistent
tubular adenomas of the colon.
Class IC. Lesions showing dysplasia: aberrant differentiation
and the appearance ofsome cells with some of the properties of
cells seen in fully evolved primary cancer The lesions show
the aberrant differentiation of Class IB. Within the areas of
aberrant differentiation atypical cells appear. Such cells are
large with prominent and usually hyperchromatic nuclei. The
individual cells may be indistinguishable from some cells seen
in overt cancer; the lesions of Class III. However, there are
differences. The atypical cells of Class IC tend to be separate
from one another; they do not appear in contiguous array.
After limited and focal growth in an initial lesion as a
manifestation of tumour progression, growth again ceases.
The lesions become indolent. Regression is not as common as
in the initial lesion. Progression to Class II lesions is rare,
but occurs. Representative and characteristic lesions include:
(1) A melancytic nevus with dysplasia (the dysplastic nevus).
(2) Persistent hepatocyte nodules with alteration of the cell
cycle (3) Squamous papillomas with atypia (actinic keratoses
in man). (4) Colonic adenomas with cytologic atypia.
Class II. The intermediate lesions
The growth of the intermediate lesions is not temporally
restricted, but the lesions are confined to the tissue compart-
ment of origin. They may, however, focally extend into the
immediately subjacent mesenchyme without evidence of the
ability to grow in that mesenchyme. Class II lesions do not
metastasise. As in previous steps in tumour progression,
intermediate lesions arise as a focal event within a preceding
lesional step, step IC, for example. Growth of intermediate
lesions is usually quite slow but rarely ceases. The cells of
Class II lesions are in contiguous array and there is a high
probability of progression to the next lesional class. Prior to
this step, the lesions of tumour progression tend to regress or
become stable. The high probability of progression of Class
II lesions to Class III is their most important biological
property.
Lesional prototypes are readily characteristed by behaviour
and histologic criteria. The prototypic lesions are confined to
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ance of the cells the lesions are commonly called by terms
such as carcinoma in situ. This introduces major problems of
nomenclature because Class II lesions do not have many of
the properties of cancer. In fact, they lack its cardinal pro-
perties, except for temporally unrestricted growth. Conse-
quently, I am hesitant to use terms such as carcinoma in situ,
for its seems to me to be a contradiction in terms; the perfect
oxymoron. Having said this, I have explained the quotation
marks around the following lesions which exemplify Class II
steps in neoplasia. (1) 'Squamous cell carcinoma in situ'. (2)
'Melanoma in situ'. (3) 'Carcinoma in situ' within an adeno-
matous colonic polyp. (4) Proliferative nodules within hepa-
tocyte nodules (nodules within nodules). In spite of major
semantic problems, some of these terms are so widely used,
they are unlikely to be extricated from the lexicon ofneoplas-
tic terms and 'in situ malignancy' will likely be a common
term for Class II lesions.
Class III. Primary invasive cancer
The lesions are temporally unrestricted in growth, grow in
two or more tissue compartments, including the mesenchyme
of the primary site, and may have competence for metastasis.
Class IIIA: Primary cancer without demonstrable competence
for metastasis The excision of virtually any primary Stage I
cancer results in cure of some percentage of cases. This
percentage is frequently greater than 50% and may be
higher. It seems unlikely that this significant percentage is
due to extirpation at some propitious time; some limited time
prior to the development of micrometastatic disease. An
alternative possibility is that many primary cancers, even
those showing growth in the mesenchyme of the primary site,
may lack competence for metastasis and, possibly, would not
have acquired such competence had they been left in place.
Squamous cell carcinomas arising in actinic keratoses are
rarely, if ever, associated with metastases. Carcinoma of the
colon that does not extend to the muscularis propria is not
associated with metastasis.
Class IIIB: Primary cancer with manifest competence for
metastasis This class of lesions completely satisfies the
definition of a primary invasive, tumourigenic cancer as the
lesions have the ability to grow in three or more tissue
compartments: the site of origin of the primary cancer, the
mesenchyme of the primary site, and one or more distant
sites. Squamous cell carcinoma of the skin that deeply
invades the reticular dermis may metastasise. Carcinoma of
the colon that extends through the muscularis propria is also
associated with some incidence of metastatic disease.
Class IV. Metastases
It is beyond the scope of this paper to discuss either the
patterns of blood vascular metastasis or the biology of
metastatic deposits. Two aspects of metastasis should be
mentioned. First, a malignant neoplasm, whether primary
or secondary, has a compelling growth preference over the
surrounding tissues. If cells manifesting such a growth pre-
ference remained confined to a single site, the expanding
tumour probably would become completely necrotic or
would differentiate and cease growth. The continuance of the
neoplastic sysem would seem to be dependent on the escape
of cells from a site, either primary or secondary. Cells in a
distant metastatic site, by definition, have full metastatic
competence. Consequently, it seems quite reasonable to sug-
gest that metastasis from metastasis is a routine aspect of
neoplastic biology. It would then follow that therapeutic
mechanisms that interrupt the metastatic pathway might
have their most important effect on blocking metastasis from
metastasis. The cells of a metastasis that could not escape
from the site would surely die or differentiate. Second, a
cardinal property of malignant neoplasia is the ability to
grow in the mesenchyme of the primary and the secondary site
usually without an intervening intact basement membrane zone.
Malignant cells do not grow in the parenchyma of a secon-
dary site; growth is in the mesenchyme. The mesenchyme of
the distant site is foreign and may require a long period of
tumour adaptation to the extracellular matrix (mesenchyme)
of that site prior to significant growth.
The existence of different patterns and pathways of metas-
tasis suggests that there may be subsets of cells in a primary
cancer with properties that allow for their selection by
specific organs and tissues. The following pathways are com-
mon, distinctive metastatic pathways.
Lymphatic metastatic pathway without the blood vascular
metastatic pathway In all solid tumour systems (certainly
the epithelial ones) some primary tumours are associated
with metastasis to regional lymph nodes and, following
therapy, are cured. Such behaviour again prompts questions
of importance in tumour biology. Are there primary tumours
that have produced a subset of cells capable of completing a
lymphatic metastatic pathway, but incapable of completing a
blood vascular pathway? If this should be the case, can such
lymph node deposits acquire the capacity for blood vascular
metastasis by further tumour progression in the lymph
nodes? The lymphatic metastatic pathway could well be a
'route restricted metastatic pathway' (see 'organ restricted
pathway', below). It is mentioned here to emphasise that
some lymphatic metastases may not reflect progression of a
primary tumour to complete metastatic competence.
Lymphatic metastatic pathway with concurrent or subsequent
blood vascular metastases The concurrent presence of lym-
phatic and blood vascular metastases indicates, in all like-
lihood, that a tumour has a subset of cells capable of
completion of both kinds of metastatic pathways. It may well
be that cells capable of completing the blood vascular path-
way can also complete the less complex lymph vascular
pathway. When blood vascular metastases follow, by some
time (more than a year, for example), lymph node metas-
tases, tumour progression may have occurred within the
lymph node deposit. An alternative possibility posits that
blood vascular metastases occurred at the time of the lymph
vascular metastases, but their manifestation was delayed.
Such a delay could be related to adaptation of tumour cells
to a foreign (distant) extracellular matrix.
Blood vascular metastases without demonstrable Iymph vas-
cular metasatases Such metastases may reflect a paucity,
relative or absolute, of lymphatic vessels at the site of the
primary tumour. Primary tumours with an exuberance of
blood vascular angiogenesis may have the majority of cells
capable of metastasis entering venules in preference to lym-
phatics.
Organ restricted metastatic pathways Metastases may, from
time to time, be limited to a single organ or tissue. Common
restricted pathways include cutaneous metastases and metas-
tases to the lungs or brain. Such patterns of spread may
reflect the existence of cells only capable of growth in the
mesenchyme specific to a given organ or tissue. Such specific
pathways have been clearly demonstrated experimentally
(Morikawa et al., 1988; Zetter, 1990).
Melanocytic neoplasia as a model for tumour progression
Class l. The precursor lesions. The melanocytic nevus. Growth
is temporally restricted.
Class IA. The initial lesion. The common acquired melanocytic
nevus. Growth, differentiation and disappearance are evi-
dent in the clinical behaviour of the ordinary mole and in the
histologic changes that correlate with its distinctive life his-
tory. Melanocytic nevi appear between the 6th month and
2nd year of life. Initially, the lesion is a flat, tan dot. Enlarge-
ment occurs slowly at its periphery and, when the lesion is
2-3 mm in width, it gradually becomes elevated. With fur-
ther elevation pigment synthesis diminishes, and the mole
becomes a flesh coloured tag of skin. Following this the634 W.H. CLARK
lesion may slowly flatten and disappear. The whole process
covers one to four decades. We have observed individual
moles progress from flat, tan-brown to soft skin tags in 4-6
years, but the appearance and disappearance of the entire
population of moles of a given individual covers several
decades. Normal people have relatively few moles by the 6th
decade of life. Interestingly, patients who have had
melanoma may show persistence of their melanocytic nevi
into the 6th or 7th decade. Histologically, the appearance,
growth and disappearance of nevi is as distinctive as the
clinical story. An increased number of melanocytes in the
basal epidermal layer is noted in the earliest visible lesions.
The subjacent mesenchyme is altered, appearing as a dense
eosinophilic band. During the period of peripheral enlarge-
ment of the nevus, melanocytes form nests at the tips of rete
ridges; an early manifestation of differentiation. With nest
formation the parenchymal neoplastic cells seem to extend
into the dermis. As the cells appear in the dermis they are
surrounded, individually or in small clusters, by a basement
membrane zone (Schmoeckel et al., 1989; Lea & Pawlowski,
1986; Yaar et al., 1988); traverse of the basement membrane
zone is not accomplished by lysis of that zone, as in 'malig-
nant' traverse of a basement membrane zone (Liotta et al.,
1987). In the dermis, the outermost cells continue to syn-
thesise pigment and are tyrosinase positive. Deeper, the cells
round up and become tyrosinase negative. Cells then elon-
gate and differentiate along Schwannian lines (Aso et al.,
1986). The elongate Schwannian cell, not the epidermal mela-
ncyte, may be the terminally differentiated cell of neural crest
origin. Finally, a delicate neuromesenchyme is formed and
the lesion disappears. This life history of a nevus and its
correlated histology is a prototype of the expected behaviour
of an initial lesion. Deviation from the expected path is the
abnormalcy. Some lesions do not follow the complete differ-
entiation pathway and become stable; arresting at different
stage of differentiation. The failure to differentiate and dis-
appear is one manifestation of progression to step IB.
The appearance and behaviour of normal nevi and all
Class I lesions have been depicted in a series of colour
photographs (Greene et al., 1985). The histology of the
various precursor lesions has also been described in detail
(Clark et al., 1984; 1990).
Class lB. A melanocytic nevus with aberrant differentiation
Persistence (in and of itself) of a common acquired melano-
cytic nevus without any subsequent differentiation and with-
out a manifest pattern of abnormal melanocytic growth may
be regarded as an aberrant phenomenon; a subtle expression
of aberrant differentiation. Aberrant differentiation is usually
manifested by an area of melanocytic growth at the periphery
of a common mole. The margin of a mole with such growth
shows an irregular flat area with an indistinct border. The
area may involve all or a portion of the border of the mole
and its presence adds asymmetry to the initial lesion and
frequently variation in colour (Greene et al., 1985). Histo-
logically, the area shows an increase in the number of
melanocytes with some elongation of hyperpigmented rete
(Clark et al., 1984). Such peripheral growth stimulates the
beginnings of the initial lesion. However, in areas of such
growth the melanocytes do not form orderly nests at the tips
of rete, but, instead, elongate clusters that tend to bridge
from one rete to the next. Most of the rete are surrounded by
a compact band of eosinophilic connective tissue; abnor-
mality of the extracellular matrix is evident early in the
flawed differentiation of an initial lesion.
Class IC. A melanocytic nevus with dysplasia Clinically IB
and IC lesions are similar. The areas of dysplasia are usually
limited to a portion of the nevus and are characteristic
histologically. The dyplastic nevus is distinguished by the
superimposition of atypical melanocytes upon the nevus with
aberrant differentiation. The atypical cells are usually ad-
mixed with the aberrant melanocytes lacking atypia at the
periphery of a normal nevus. The atypical cells may be
2 x -4 x the size of normal melanocytes, have large nuclei,
and are numerous and readily seen (Rhodes et al., 1988). An
occasional atypical melanocyte in an area of aberrant
differentiation does not warrant a diagnosis ofdysplasia. The
atypical cells do not grow contiguously with each other, as a
rule, but one may see two or three atypical melanocytes in
the basilar region of the epidermis adjacent to each other;
contiguous growth ofatypical cells is the hallmark of Class II
lesions. In some instances the atypical cells are large,
epithelioid melancoytes and these cells have an abundance of
tan cytoplasm and, usually, large nuclei. Such cells may be at
the edge of nevi, above dermal papillae, at the edges of rete,
or at the tips of rete. Their distribution is random. Some
atypical melanocytes may be seen in the subjacent dermis.
The dermis in areas of dysplasia is distinctive. Narrow bands
of brightly eosinophilic, acellular collagen commonly rim the
dermal-epidermal interface covering a distance of several rete
and papillae; an extracellular matrix change that has been
termed concentric eosinophilic fibroplasia. Less commonly
seen, but even more characteristic, is another connective
tissue change called lamellar fibroplasia. Lamellar fibroplasia
frequently appears at the tip of a rete ridge. Such rete have ill
defined nests of melanocytes at their tips. These melanocytes
are not arrayed as those in a normal nevus. They may be
spindled and a cluster of them is ill-defined. The cells blend
with the subjacent lamellar fibroplasia and contribute to its
formation. The lamellar fibroplasia is triangular in outline in
a two dimensional plane, but doubtless a cone in three
dimensions. The lamellar fibroplasia is composed of delicate
strands (cross section of a plate if it were seen in three
dimensions) of collagen alternating with elongated nuclei.
Small granules of melanin may be seen on either side of the
nuclei. One gets the impression that the cells of lamellar
fibroplasia are derived from epidermal melanocytes that syn-
thesise both collagen and malanin and are differentiating, to
some extent along Schwannian lines, for the stacked, plate-
like structure resembles a Wagner-Meissner corpuscle.
Lamellar fibroplasia also strongly suggests parenchymal
tumour cell-extracellular matrix interaction. In addition to
the connective tissue changes there are always small collec-
tions of lymphocytes about the blood vessels of the
superficial vascular plexus (Clark et al., 1990).
The atypical cells have many antigenic characteristics of
'melanoma cells' seen in Class II and Class III lesions of
tumour progression (Aronson et al., 1988). Some studies of
the antigenic profile of tumour progression stages in melano-
cytic neoplasia show distinctive differences (Holzmann et al.,
1987; Elder et al., 1989). Abnormalities of cellular DNA
content and random chromosomal abnormalities have been
reported in dysplastic nevi (Bergman et al., 1988; Newton et
al., 1988; Parmiter et al., 1988). The lesions are usually
stable, but have some risk of progression to the next class of
lesions.
Class IH. The intermediate lesionst 'in situ melanoma' and
radial growth phase melanoma: growth is not temporally
restricted but is confined to the tissue compartment of origin or
barely extends into the subjacent dermis. Actual growth in the
mesenchyme apparently does not occur
Class IIA. Malignant melanoma in situ The prototype of
this class is the kind of lesion that may evolve into an overt
malignant melanoma of the superficial spreading type (a
Class III lesion). Remnants of preceding Class I lesions may
or may not be observed histologically in Class II lesions. The
cells of Class II lesions are large, epithelioid and have an
abundance of cytoplasm filled with tan, finely divided mela-
nin. The cells tend to be contiguous with each other when
tThe terminology problem is most difficult with intermediate lesions
for they lack many of the cardinal properties of biological cancer.
The terms melanoma in situ and radial growth phase melanoma are
well established in the literature. Their use does not imply cancer, as
herein defined. The lesions behave and are intermediate between the
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compared with the atypical cells of a dysplastic nevus. The
nuclei of the distinctive cells of Class II lesions are large and
hyperchromatic. Nucleoli may be prominent. Although the
individual melanocyte is atypical, having the just described
features, the overall appearance of the melanocytes is one of
homogeneity; variation from cell to cell is not prominent in
most cases. Cells are disposed in nests and as individual cells
at all levels of the epidermis, including the stratum granu-
losum. Individually disposed cells may dominate over those
in nests. The pattern of the cells may simulate Paget's disease
of the breast.
Class IIB. Primary malignant melanoma in the radical growth
phase This class of neoplastic lesions shows the histology of
in situ melanoma and focal extension of similar cells into the
subjacent papillary dermis. The cells in the dermis are dis-
posed as individual cells and as small clusters. No focus of
dermal cells seems to have a growth preference over the
others. Growth apparently does not occur in the dermis, but
the cells in that location arrive there from the epidermis,
which is apparently the site of tumour cell division in this
stage in tumour progression. The dermal cells are usually
surrounded by an intact basement membrane zone, which
seems to be continually formed around the individual cells
and the small nests of cells. Of course, such histologic pic-
tures are usually interpreted as invasion, but in spite of the
presence of 'melanoma cells' in the dermis metastases do not
occur. We have followed 149 such cases for > 8 years with-
out any evidence of metastasisl. This observation brings into
focus a critical point in tumour biology: invasion as deter-
mined by the routine methods of pathology does not
necessarily mark a tumour as having metastatic competence.
Invasion and metastasis are, to some extent, disparate pro-
perties. Invasion, as exemplified by radial growth phase mela-
noma, precedes and is necessary for metastatic competence.
The next tumour progression step, actual growth in the
mesenchyme, is a marker, albeit an imperfect marker, of
metastatic competence. The cells that extend into the dermis
in the radial growth phase initiate a form of tumour-matrix
interaction that results, in due course, in competence for
growth in that matrix (dermis), the expression of which is
vertical growth phase.
Class III. Primary malignant melanoma with manifestation of
growth in the mesenchyme of the primary site
Progression to overt cancer is not the end of tumour progres-
sion. Primary melanomas illustrate continuation of tumour
progression within an established cancer better than most
neoplastic systems. One can frequently observe, clinically and
microscopically, evidence of tumour progression in primary
melanomas. This is due, in part, to changes in pigment
synthesis with the sequential appearance of different popula-
tions of cells in the primary neoplasm. For example, a pink
nodule may appear within a previously brown-black mela-
noma. Thus, tumour progression is manifested, in most
melanomas, by a distinctive biphasic growth pattern. In the
first phase the tumours slowly enlarge along the radii of an
imperfect circle; net growth is at the periphery of the lesion.
This pattern of growth is the radial growth phase of mela-
noma and has just been discussed as the second part of the
Class II lesions. The second phase of growth, the vertical
growth phase, of the primary lesion is characterised by focal,
dermal growth somewhere within the initial growth phase. In
due course the second growth phase forms an expansile
nodule; a pattern of growth that is similar to that seen in a
metastasis and one that may be a portent of metastasis. The
two growth phases of a primary melanoma are not only
different in their macroscopic (clinical) and microscopic
presentation, but have distinctive antigenic differences. In
addition, cells derived from the different growth phases have
different in vitro characteristics. Elder et al. have shown that
radial growth phase melanomas have an antigenic profile
similar to dysplastic nevi, while vertical growth phase mela-
nomas present an antigen profile similar to metastatic mela-
noma (Elder et al., 1989). Herlyn et al. have shown that cells
derived from radial growth phase melanomas rarely produce
permanent cell lines and those few cell lines that have been
maintained are not tumourigenic in nude mice (Herlyn et al.,
1987).
Class IIIA. Primary malignant melanoma in the vertical
growth phase without manifest competence for metastasis
Some 63% (207/328) of primary, vertical growth phase
melanomas do not show metastatic disease after 8 years of
follow-up. There are many possible explanations for this lack
of manifest competence for metastasis. The biological
inferences of attributes that are independently predictive of
survival will be discussed in the following section (vertical
growth phase melanomas with metastases). Among the
diverse explanations for the lack of metastasis there could
well be a subset of tumours capable of growth in the mesen-
chyme of the primary site, but incapable of completion of
any step in a metastatic pathway, except for invasion and
some motility in the dermis. If such a subset can be identified
and characterised, it would clearly demonstrate that invasion
and the other properties required for metastasis are not
acquired as a group of attributes, but as properties acquired
seriatim. At present, one can record those attributes likely to
be associated with long periods of disease free survival. The
following is a list of such attributes derived from the data
base of the Pigmented Lesion Group of the University of
Pennsylvania. It should be here emphasised that the list is for
primary melanomas in the vertical growth phase. Radial
growth phase melanomas have not been associated with any
form of metastasis in our experience and are eliminated from
a discussion of metastatic competence.
Vertical growth phase melanomas having all of the follow-
ing characteristics have not been associated with metastases
in our data base. Thirty-two cases have had all of the att-
ributes and none have shown metastases.
(1) Mitotic rate: 0mm-2.
(2) The presence of brisk tumour infiltrating lymphocytes.
(3) Thickness: <1.70 mm.
Class IIIB. Primary malignant melanoma in the vertical
growth phase with metastasis The following attributes are
independently predictive of survival in Stage I primary mela-
nomas and, consequently, are the best candidates for a posi-
tive or negative relationship to metastatic pathways. (1)
Mitotic rate mm2 A quite attenuated list of steps in a
metastatic pathway would include: (a) the number of cells
produced by a primary neoplasm in a given time; (b) the
number of cells migrating away from the primary site; (c) the
number of cells entering a venule or a terminal lymphatic; (d)
the number of cells surviving in the blood or lymph vascular
pathway; (e) the number of cells escaping from vascular
pathway; and (f) the number of cells surviving and replica-
ting at the metastatic site. Regardless of how long one makes
such a list of steps in the metastatic pathway, it must ulti-
mately be related, in some way, to the rate of production of
the cells of a primary melanoma. Attesting to this statement
is that no other attribute has the survival predictive power of
mitotic rate (Clark et al., 1989). In vertical growth phase
melanomas, 95% (39/41) of patients with a mitotic count of
0mm~2 survive >8 years, while only 38% (26/68) with a
mitotic count >6 mm-2 survive > 8 years (Figure 1). At 10
years follow-up, 206 patients who have been disease free had
a median mitotic rate of 1.1 mm-2, while patients dying
of disease during the 10 year period had a median mitotic
rate of 6.2 mm-2 (Data Base of the Pigmented Lesion Study
Group, 1991). (2) Tumour infiltrating lymphocytes The pre-
sence of a brisk infiltrate of tumour infiltrating lymphocytes
(TIL's) is associated with death due to metastatic disease in
:All but two of these cases have been followed for > 10 years. One
patient died of myocardial infarction after 8 years and three were
lost to follow-up after 8 years.636 W.H. CLARK
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Figure 1 Stage I vertical growth phase melanoma. Mitotic rate
(no./sq.mm) - outcome. Dead of disease or alive at 8 years. M,
DOD; 0, Alive.
only 11% (6/52) of cases, while the absence of tumour
infiltrating lymphocytes is associated with a 41% (44/108)
mortality due to disease (Figure 2). To qualify as tumour
infiltrating lymphocytes the cells must actually infiltrate and
disrupt the tumour. Lymphocytes at the base of the tumour,
regardless of density, do not influence outcome. One tends to
immediately attribute the significance of TIL's to a cytotoxic
immune function. However, there are other possible, even
plausible, roles for the effect of tumour infiltrating lympho-
cytes. A brisk infiltrate of lymphocytes could inhibit cell
motility or block entry into vascular spaces. (3) Tumour
thickness Increasing tumour thickness is clearly related to
increasing mortality (Figure 3). The significance of increasing
thickness is independent of other attributes, and, specifically,
independent of mitotic rate. Why is thickness significant? It
could be a surrogate for time during which futher tumour
progression occurred. New cell populations with enhanced
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Figure 2 Stage I vertical growth phase melanoma. Tumour infil-
trating lymphocytes. Outcome dead of disease or alive at 8 years.
*, DOD; 0, alive.
Thickness-r m
Figure 3 Stage I vertical growth phase melanoma. Thickness
-
outcome. *, DOD; 0, alive.
capacity for metastasis could have appeared during the time
required for increasing thickness. Thick vertical growth phase
tumours have chromosomal abnormalities, usually at chro-
mosomes #1, #6 and #7 and genetic alterations appear in
parallel with increasing biological aggressiveness (Nowell,
1989; Parmiter & Nowell, 1988). Increasing thickness also
results in an increasing interface with the vascular bed. If one
treats the vertical growth phase as a sphere of tumour cells,
doubling of the thickness of the tumour increases its outer
surface, the surface of the sphere, by 4-fold. If one con-
sidered the interstices of the tumour, the interface with the
vascular bed is increased many fold. A corollary of increasing
interface with the vascular bed is an increasing interface with
the extracellular matrix. We have observed that increasing
thickness and invasion of the reticular dermis (Level IV
invasion) is associated with a decrease in formation of the
basement membrane around the tumour cells (unpublished
observations). Tumour cell interaction with the nonbasement
membrane extracellular matrix is then possible. Such inter-
action may be necessary for adaptation to and continuing
growth in the extracellular matrix and may also be related to
acquisition and manifestation of metastatic competence. In
summary, increasing thickness is correlated with progressive
chromsomal abnormalities; an increasing interface with the
vascular bed (probably associated with angiogenesis); and
progressive interaction with the extracellular matrix. The ex-
pression of many tumour cell properties could be the result
of signals between the abnormal tumour cells and the extra-
cellular matrix, a reciprocal interaction. (4 & 5) Anatomic site
of the primary and sex of the patient Female patients do
better than male patients and patients with extremity lesions
(excluding volar-subungal lesions) do better than those with
axial lesions (head, neck, and trunk). Divergent behaviours
that is site dependent again brings up the possibility of
influence by matrix-tumour interaction. The dermis varies in
form at different sites, and may well vary between the two
sexes. Such variations could influence the kind of tumour
evolving at a given site and in a given sex; the phenomenon
of topooncogenesis (to alter Edelman's term of topobiology
and apply it to the abnormal life form that is cancer) (Edel-
man, 1989). (6) Histologic foci of complete regression Such
foci could be due to immunoselection of a population of cells
that has escaped the immune system. Prehn has postulated
another mechanism for the adverse significance of regression
(Prehn, 1990). He proposes that during the evolution of a
melanoma two properties concerning lymphoid infiltrates
progress independently. Tumour cells give off an attractant
a)
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for lymphocytes and this substance may decrease with pro-
gression. Secondly, tumour cells may be dependent, initially,
on lymphoid cell products for growth and this dependence
decreases with progression. Prehn further suggests that some
melanoma cells may lose the power to attract lymphoid cells
before they lose growth dependency. Regression may then
occur, but other parts of the clone of cells in the vertical
growth phase may lose growth dependency along with their
ability to attract lymphoid cells. In such an instance, regres-
sion may mark a poor prognosis because cells adjacent to the
regression can no longer attract lymphocytes and no longer
need to do so in order to grow; they have escaped depen-
dence on a part of their microenvironment.
From the foregoing considerations one may derive a list of
attributes associated with metastatic disease. Fifteen patients
in our data base have had all of the following attributes and
all have developed metastatic disease.
(1) A mitotic rate >6mm2.
(2) Absence of tumour infiltrating lymphocytes.
(3) Thickness >3.60 mm.
Metastasis
The different metastatic pathways In cutaneous melanocytic
neoplasia there are three important observations suggesting
the existence of biologically different metastatic pathways.
First, of those melanomas that metastasise, 18% (see follow-
ing discussion) involve regional lymph nodes without subse-
quent dissemination of any kind. In contrast, metastasis of
melanoma to any other site, with few exceptions, is followed
by death due to disseminated disease. Second, the terminal
lymphatic of the skin usually does not have a basement
membrane zone. The lymphatic endothelium abuts directly
against the dermal mesenchyme. Entry of mobile tumour
cells into the terminal lymphatic could be a much simpler
task than entry into a venule. Third, there exists an uncom-
mon form of melanoma that seems to be a natural experi-
ment with regard to a distinctive metastatic pathway. Reed
has described a Spitz type of minimal deviation melanoma
with metastasis to regional lymph nodes without dissemina-
tion (Reed, 1988). Smith et al. have reported six cases of
metastasis of 'malignant Spitz nevi' to regional lymph nodes
without subsequent disease. I have seen four similar cases.
The primary lesions are large, thick tumours that frequently
involve the subcutis. The cells in the lymph nodes are vir-
tually identical with those in the primary. These rapidly
growing tumours of young people (essentially, the first two
decades of life) seem to have the capacity for lymphatic
metastasis but do not seem to be able to successfully compete
any other metastatic pathway. this may be related to the
lymphatic invasion frequently seen in benign Spitz tumours
(Howat & Variend, 1985). The relative incidence of the
different metastatic pathways in our data base is shown in
the following list. The data are based upon 328 vertical
growth phase melanomas. In this data set there were 121
(37%) cases with some form of metastasis during a period of
< 8 years. During that follow-up period, the remaining cases
(207) did not show metastases.
Lymphatic metastatic pathway without the blood vascular
metastatic pathway 22/121 (18%).
Lymphatic metastatic pathway with concurrent or subsequent
blood vascular metastases 47/121 (39%).
Blood vascular metastases without demonstrable lymph vas-
cular metastases 52/121 (43%).
Organ-restricted metastatic pathways Occasionally (<1%)
metastases seem to be limited to a single organ. In melanoma
this is most commonly seen as cutaneous metastases. Occa-
sionally, even when beyond the region of the primary,
removal of cutaneous metastases, as they appear, is followed
by cessation of the phenomenon and no further disease is
manifest. One gets the impression that the tumour cells do
not have the capacity for growth in any mesenchyme other
than the dermis, the original mesenchyme of the primary
melanoma.
Tumour progression in other neoplastic systems
It is not an objective of this discussion of the analogies
between the lesions of tumour progression in diverse neoplas-
tic systems to precisely describe all of the sequential lesions
of each system. We would like to show that neoplastic
systems are remarkably similar, and these very similarities
form a conceptual framework for neoplasia and may indicate
research directions of importance in the understanding of
some of the basic problems in neoplasia. For example, the
initial lesion of neoplasia is a focal benign growth that is
probably clonal (Burns, 1989); is largely independent of the
inductive mechanisms (see following discussion); and is a
lesion that usually disappears by a programmed pathway of
differentiation. The molecular biology of this primary re-
sponse to a carcinogen - growth, cessation of growth, and
disappearance - has not been extensively investigated. The
failure of a given lesion to follow the programmed pathways
of an initial lesion (Class IA) - growth, cessation of growth,
and disappearance - is the first step in a pathway to cancer;
the first step in carcinogenesis. Knowledge of the principles
of tumour progression is at the foundation of the present
control of mortality due to cancer. Such control is largely
based upon knowledge of cancer risk afforded by the exist-
ence of some of the Class I lesions. Those individuals identi-
fied as having a high risk for any given form of cancer must
then have appropriate education, follow-up and therapy. In
melanoma, for example, Masri et al. have shown that mela-
nomas diagnosed in follow-up of patients with a family
history of melanoma had an average thickness of 0.52 mm,
while the melanomas of the index cases of that study had a
average thickness of 1.44mm (Masri, 1990). We would also
like to show that study of the individual lesions appearing
relatively early in tumour progression permits biological
inference about cancer development that cannot be derived
from the study of cells emerging at the end of tumour
progression (cells derived from fully developed primary
cancers and from metastases).
Class I lesions. Theprecursor lesions
Cutaneous keratinocytic neoplasia Demonstration of repro-
ducible behaviour in the seemingly diverse lesions of neo-
plasia requires an experimental system (Klein-Szanto, 1989).
Virtually all human neoplastic systems evolved while the
inductive mechanisms are continually active. This is obvious-
ly the case when the inductive mechanisms involve light and
cutaneous neoplasia. Light impacts upon the skin throughout
most of the life span of man. Consequently, observations of
coordinated behaviour of cohorts of lesions are confounded
by the emergence of sequential crops of lesions at all stages
of evolution and regression. If one observes, on a single
occasion, a 40 year old red-haired, freckled patient, who has
had significant sun exposure, the cutaneous neoplastic lesions
of the keratinocytic system will be quite diverse. Benign
keratoses, actinic keratoses, and, perhaps, a squamous cell
carcinoma will be present. Sorting out the histogenetic and
sequential relationships between the many lesions based upon
a single observation is likely to be impossible. The problem is
similar to the full appreciation of a complex musical canon
of eight parts when one hears only the middle of the com-
position. An animal experiment inducing a neoplastic system
permits one to play one part of the canon of neoplasia from
the beginning to the end. Experiments with syngeneic animals
with controlled dosages of carcinogens produce lesions that
behave in a uniform fashion. From such studies one may
reasonably infer that most human neoplastic systems have
lesions that are analogous with the reproducible lesions pro-
duced in experiments. A further complication of the under-
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continuing action of the inductive process on extant lesions.
For example, nothing is known about the effect of UV
irradiation on Class II lesions. Does it inhibit growth,
enhance growth, induce a new clonal tumour progression
step, or is it without effect?
The initial lesion in mouse skin induced by a chemical
carcinogen and croton oil is a squamous papilloma. Under
defined conditions such lesions grow, become indolent and
disappear via a pathway thought to be due to differentiation.
A similar papillary lesion due to HPV 16 or 18 (and some
other subtypes) occurs on the human genital skin. Many of
these papillary lesions, termed bowenoid papulosis, also
spontaneously disappear. The initial lesions, in animals, due
to UV-light are also squamous papillomas. It is quite re-
markable that such different inductive mechanisms evoke the
same initial response: a papillary hyperplasia that tends to
regress and disappear. The common initial lesion of keratino-
cytic neoplasia in human skin is a benign keratosis, a circum-
scribed area of thickening of the epidermis which is not
papillary in form. The lesions of aberrant differentiation
(Class IB) and dysplasia (Class IC) are characterised by
persistence of the intial lesion, mitotic activity above the
basal layer and, in Class IC, atypical keratinocytic hyper-
plasia. An actinic keratosis is the prototype of a Class IC
lesion and is the prototype of a lesion that may progress to
squamous cell carcinoma. It must be emphasised that most
actinic keratoses, like other Class IC lesions are indolent, end
stage lesions without a future.
Hepatic neoplasia. Microscopic islands and hepatocyte nodules
Hepatocyte nodules arise in microscopically visible islands of
altered hepatocytes. The cells of the islands show reproduci-
ble histochemical and biochemical changes (Farma & Sarma,
1987). Some are of the opinion that microscopic islands may
lead to cancer without the prior appearance of hepatocyte
nodules (Williams, 1980). The nodules are macroscopically
visible, focal proliferations of hepatocytes that are different
from and compress the surrounding liver. The phenotypic
differences include arrangement and architecture of hepato-
cytes, blood supply, cytologic and histologic appearance and
biochemical properties. Metabolic patterns are remarkably
uniform from one model of hepatocarcinogenesis to another
and, largely, from one nodule to another, including persistent
nodules. Under appropriate experimental conditions the
hepatocyte nodules differentiate and disappear, leaving a
liver that is essentially normal in appearance. Recently it has
been shown that the reversion of hepatocyte nodules to
normal liver is via a complex genetic program of different-
iation. The programmed differentiation '... points to the
physiological nature of many of the early steps in the carcin-
ogenic process' (Farber & Sarma, 1987; Farber, 1990). One
of the reasons for using analogy as an investigative tool is to
recognise important events by their clear portrayal in one
system. The demonstration and study of the disappearance of
the initial lesion in neoplasia has been done consistently in
the hepatic system and should be regarded as a prototype of
behaviour of initial lesions. The initial lesions, in Farber's
view, are not pathology but a physiological response, he has
termed clonal adaptation (Farber, 1990). Search for the ini-
tial lesion in another system may reveal its presence more
subtly manifested. The gradual differentiation and obscure
disappearance of the common acquired melanocytic nevus
may be recognised in the light of differentiation of the hepa-
tocyte nodule. If a hepatocyte nodules is to progress, it fails
to differentiate and shows a focal proliferation of a subset of
cells. An additional step, one quite likely to lead to carcin-
oma, is the proliferation of a subset of cells showing an
alteration of the cell cycle within persistent hepatocyte
nodules. Failure of differentiation and nodules within nodu-
les are analogies with Class IB and IC lesions in other
neoplastic systems.
Colonic neoplasia Vogelstein and his colleagues have shown
that three sequential adenomas, early, intermediate, and late,
precede carcinoma of the colon. Such designations parallel
polyp classifications by pathologists. Late adenomas usually
show significant cytologic atypia. Adenomas regress as do
melanocytic nevi, squamous papillomas and hepatocytes
nodules (Feinberg et al., 1988). As a rule the sequential series
of qualitatively different polyps is accompanied by progres-
sive increase in size of the lesions. The colonic polyp
sequence is easily fitted into the Class IA,IB, and IC scheme
of this presentation. The parallels between colorectal cancer
development and other neoplastic systems are easily seen.
Vogelstein's work has provided, in addition, evidence that
progression from the polyp sequence to carcinoma to metas-
tasis is associated with the sequential accumulation of genetic
abnormalities (oncogene activation and inactivation of sup-
pressor genes ) (Fearon et al., 1990). His findings do not
explain the behaviour of the sequential lesions of neoplasia,
but should be a stimulus for the orderly investigation of
neoplastic development in other systems. Investigation from
the beginning, not from the end. If the lesions of neoplastic
systems are analogous, the cellular mechanisms of their
development should be similar.
Class II lesions. The intermediate lesions
Cutaneous keratinocytic neoplasia The prototype of inter-
mediate lesions is squamous cell carcinoma in situ in a
stratified squamous epithelium such as the epidermis or uter-
ine cervix. Such lesions show progressive growth, which is
usually quite slow. Histologically, they differ from Class IC
lesions in that all of the cells of the lesion are atypical and
are in contiguous array throughout the entire thickness of the
epithelial surface. The characteristic lesions are entirely above
the basement membrane zone and are not associated with
any apparent ability to metastasise. Additional lesions will
also show cells below the basement membrane zone. These
cells are disposed individually, as a rule, and are also appar-
ently unable to metastasis. Lesions with a few cells below the
basement membrane zone do not have the capacity for
growth in the mesenchyme; a capacity that may be one
requirement for acquisition of metastatic competence.
Hepatic neoplasia The detailed study of the later steps of
cancer development in the rat liver has not been done. The
extensive investigations of hepatocarcinogenesis have concen-
trated on initiation, promotion and the earliest steps of tumour
progression; steps preceding cancer. In fact many studies of
experimental carcinogenesis seem to treat the appearance of
invasive cancer as an end point. The complex events occurr-
ing within what we here term Class II and Class III lesions
have not been the subject of detailed inquiry in experimental
cancers. However, a group of lesions designated as nodules
within nodules, while not overtly invasive, does progress to
invasive cancer. Consequently, they seem to be analogous
with Class II lesions. Transplantation of the lesions desig-
nated as nodules within nodules to the spleen of syngeneic
animals is followed by progression of the transplanted lesion
to overtly invasive cancer (Farber & Sarma, 1987).
Colonic neoplasia Late adenomas commonly show areas
that in other neoplastic systems would be called carcinoma in
situ. One may also see, in these late adenomas, areas of
extension below the basement membrane zone. Actual
growth apparently does not occur in the mesenchyme of the
site. As long as such extensions below the basement mem-
brane zone do not extend to the lamina propria, the lesions
are not termed carcinoma for no metastases occur (Plaz,
1978). Such lesions are precise analogies with radial growth
phase melanomas. In colonic neoplasia the term carcinoma is
not used for lesions that have no potential for metastasis.
Obviously such lesions are prototypes of the Class II lesions
as discussed in this paper.
Class III lesions. Primary invasive cancer with manifestation of
growth in the mesenchyme ofthe primary site
These lesions are the lesions with some potential for metas-
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manifest in melanocytic neoplasia are not discussed at length
in other forms of neoplasia. Study of different neoplastic
systems, however, shows clear analogies with melanocytic
neoplasia.
Cutaneous keratinocyte neoplasia Most squamous cell car-
cinomas are superficial and arise in actinic keratoses. Such
lesions do not metastasise, for practical purposes, and are
similar to radial growth phase melanoma or early vertical
growth phase melanoma. The carcinomas that deeply invade
the reticular dermis, or carcinomas near mucocutaneous
junctions will show metastasis, but not commonly. Progres-
sion to full metastatic competence is not as common in
cutaneous squamous cell carcinoma as it is in melanoma.
Colonic neoplasia Those tumours that invade only into the
submucosa, without involvement of the muscularis propria,
are not associated with metastatic disease. Such lesions are
similar to radial growth phase melanoma. Deeper involve-
ment of the bowel wall and extension through the bowel wall
parallel some aspects of the varying prognosis of vertical
growth phase melanoma. Other prognostic attributes, such as
mitotic rate and tumour lymphocytic infiltrating lympho-
cytes, are not routinely recorded in colon carcinoma. Even
with lymph node involvement, however, some colon carcin-
oma patients survive. There always seems to be some subset
of patients with primary colon carcinoma whose tumour has
not acquired metastatic competence.
A tabular comparison of tumour progression in different
neoplastic systems
Class I and Class II lesions of the different neoplastic systems
are compared in tabular form (Table I). In the same table the
relative incidence of the different metastatic pathways of
melanoma is shown.
Neoplastic systems without demonstrable precursor (Class I)
lesions: direct tumour progression
Individual primary cancers sometimes appear without mani-
fest precursor lesions in both human and experimental
cancer. Foulds has termed the phenomenon direct tumour
progression. He stated, 'It seems to be a general rule, to
which no clear exception has been demonstrated, that in
every tissue in which a particular kind of malignant tumours
usually develops along an indirect path through visible inter-
mediate lesions, a similar kind of tumour sometimes emerges
with its definitive characters established from the beginning
and without tranversing any intermediate lesion during its
clinically evident course' (Foulds, 1969). The phenomenon is
rare in experimental neoplasia in syngeneic animals, but
seems to be more common in man. In melanoma, for exam-
ple, some 50-60% of primary melanomas have a dysplastic
nevus contiguous with the primary melanoma or have dys-
plastic nevi present elsewhere on the skin. About 90% of
patients bearing melanoma have some form of precursor
lesion (Class I) either adjacent to the primary melanoma or
somewhere on the skin. Regardless of the precise figures,
there is some subset of primary melanomas that develop
without evident precursor lesions. There are several possible
explanations for this apparent manifestation of direct tumour
progression. (1) The growth of the primary melanoma ablates'
the evidence of the precursor This doubtless occurs. Sagebiel
has shown that small (thin) melanomas of the superficial
spreading and nodular type are more commonly associated
with adjacent precursors than are thicker tumours. We have
made similar observations on melanomas in our data base. In
melanomas of the superficial spreading and nodular types,
the incidence of melanocytic precursor lesions adjacent to the
primary melanoma by thickness groups is as follows. The
first figures are those of the University of Pennsylvania Pig-
mented Lesion Group and the second those of the University
of California at San Francisco (Data Base of the Pigmented
Lesion Study Group, 1991; Sagebiel, 1991).
(a) <0.76 mm 58% (121/207) UCSF ... 64% (429/670)
(b) 0.76-1.69mm 47% (65/138) UCSF... 64% (419/639)
(c) 1.70-3.60 mm 42% (40/95) UCSF ... 44% (198/401)
(d) >3.60 mm 26% (14/53) UCSF ... 34% (57/169)
(2) Direct tumour progression actually occurs in the sense
that something comparable to in vitro transformation of a
putatively normal cell in a single cell generation occurs in
vivo. A comment on this possibility with compelling evidence
one way or the other approaches the impossible. Epidemio-
logic evidence is strongly against the possibility. One may
surmise that if such a pristine example of direct tumour
progression did occur, it would be seen in all age groups and
perhaps more commonly in the young; the latter having cell
systems quite susceptible to injury. As a matter of fact,
melanomas occurring without any precursor anywhere on the
skin or contiguous with the tumours are found in older
patients. Such an observation suggests a long period of
induction, not a 'hit' transforming a cell in one or a few
generations. In vitro studies provide further evidence against
an idealised form of tumour progression. Putatively normal
cell lines usually require several sequential events, such as
oncogene activation, for malignant transformation (Nichol-
son, 1987). (3) Structurally atypical cells, similar in appear-
ance to some cells in fully evolved primary cancers, develop
without there being a clinically manifest lesion This concept
posits a concatenation of events over time in single cells
leading to cytologic atypia, without the formation of recog-
nisable Class I lesions; in one sense such a view implies
something akin to tumour progression could occur in single
cells. Such cells may be numerous, but they are separate from
each other. The first line of evidence supporting the concept
that scattered atypical cells not associated with a demon-
strable lesion afford a melanoma risk is that atypical cells
within a demonstrable precursor are the primary source of
risk of these lesions. For example, in studying the risk of
melanoma development when patients have precursor lesions,
the greatest risk (400 x the baseline population risk) is
afforded by those having a family history of melanoma and
histologic dysplasia in two or more nevi (Green et al., 1985).
The histologic dysplasia associated with such a risk was
characterised by the presence of readily recognisable atypical
melanocytes. One may infer from this observation that much
of the melanoma risk was associated with the atypical mela-
nocytes. Similar risk of cancer seemingly due to the develop-
ment of atypical cells in precursor lesions is seen in breast
and cervix neoplastic development (Ferenczy & Winkler,
1987; Dupont & Page, 1985; Page & Dupont, 1990). Thus, in
heritable melanoma, the breast, and the cervix, atypical cells
affording cancer risk are present in recognisable precursor
lesions. Therefore, the development of atypical cells, ran-
domly scattered within a normal tissue, should also be a risk
factor for the development of cancer. Atypical melanocytes
are seen in light-exposed skin of patients >50 years of age,
who have type I or type II skin. These cells are a likely
source of origin of cancer in direct tumour progression.
Collectively, these randomly scattered atypical cells and the
extensive atypia of Class IC lesions consitute the precursor
states.
A summary with a discussion of critical events in neoplasia
This paper proposes that the sequential events of tumour
progression are similar in all neoplastic systems and these
events are usually required for cancer to develop. Thus,
tumour progression is a fundamental part of the 'intimate
nature' of cancer (Nicolson, 1987). The following phenomena
are encompassed under the concept of tumour progression as
it relates to the development of cancer.
Known inductive mechanisms of human and experimental
cancer produce a focal, clonal proliferation of cells that640 W.H. CLARK
Table I A COMPARISON OF THE LESIONS OF TUMOUR PROGRESSION IN NEOPLASIA
(Read down for tumour progression. Read across for prototypic lesions in different neoplastic systems)
Melanocytic neoplasia Keratinocytic neoplasia Colorectal neoplasia
Lesional class (human) Hepatic neoplasia - rat (mouse andhuman) (human)
Class I
Precursor lesions Temporally restrictedgrowth. Growth confined to the tissue compartment oforigin
JA. Initial lesion. Clonal Ordinary mole with Microscopic islands Squamouspapilloma Tubular adenoma
proliferation of structurally regression via followed by hepatocyte with regression via (small adenoma) with
benign cells that disappears differentiation nodules with regression differentiation regression
via differentiation. (melanocytic nevus) via differentiation
Progression to the subsequent
steps of tumour progression is
invariant in order but is not
inexorable
Class IB. Aberrant Abnormalpattern of Persistent nodules with Squamous papilloma with Intermediate adenoma
differentiation in intial lesion. melanocytic growth in an 'spontaneous' proliferation failure ofdifferentiation.
Focal growth of a subset of ordinary mole of a discrete subset of the Mitoses above the basal
cells in a pattern different total cell population of the layer
from the initial lesion. From nodule
this step forward
differentiation is diminished,
but not absent
Class IC. Dysplasia. Aberrant Melanocytic nevus with Persistent nodules with Squamouspapilloma with Tubulo-villous adenoma
differentiation plus some cells dysplasia spontaneous proliferation atypia. Actinic keratosis with severe atypia or large
with cytologic atypia of a discrete subset of the (human lesion) tubular adenoma with severe
total cell population of the atypia (late adenomas)
nodule. Cell death and
altered shut-off of the cell
cycle.
Class II Temporally unrestrictedgrowth. Growth confined to tissue compartment oforigin or is only microinvasive.
Intermediate lesions Growth does not occur in mesenchyme ofprimary site
All cells of lesions are 'Melanoma in situ'. Radial Nodules within nodules Squamous cell carcinoma Large tubulovillous
atypical and grow in growth phase primary in situ. Microinvasive adenoma with carcinoma
contiguous array melanoma carcinoma in situ. Invasive carcinoma
above the level of the
muscularis mucosae
Class III Temporally unrestrictedgrowth. Growth occurs in the mesenchyme ofthe primary site.
Primary cancer Metastases may or may not occur
A nidus of cells in the primary Primary melanoma in the Invasive hepatocellular Invasive squamous cell Colorectal carcinoma
tumour having most properties vertical growth phase. cancer with potential for carcinoma extending into or through
of cancer cells including the Thirty-seven per cent (37% metastasis; a potential not the muscularis mucosa
ability to involve three or - 121/328) exhibit always expressed
more tissue compartments metastatic competence.
(metastasis). Properties related Nine years follow-up
to metastasis are expressed in
some but not all Class III
lesions
Class IV
Metastasis The diversepatterns ofmetastatsis inprimary stage I verticalgrowthphase melanoma
Lymph node metastases with-
out subsequent metastases of Seven per cent (7% - 22/328) of vertical growth phase melanomas ... 18% (22/121) of tumours with
any kind metastasis. Nine years follow-up
Blood vascular metastases
with prior or concomitant
lymph node metastases Fourteen per cent (14% - 47/328) of vertical growth phase melanomas ... 39% (47/121) of tumours with
Blood vascular metastases metastasis. Nine years follow-up
without prior or concomitant Sixteen per cent (16% - 52/328) of vertical growth phase melanomas ... 43% (52/121) of tumours with
lymph node metastases metastasis. Nine years follow-up
Metastases from metastases
disappears via a programmed pathway of differentiation.
This first response to a carcinogen has been termed the initial
lesion. The form and behaviour of the initial lesion is the
reference for the nature of aberrant form and behaviour in
subsequent Class I lesions. The initial lesion is the manifesta-
tion of clonal adaptation as described by Farber and progres-
sive state selection as described by Rubin (Farber, 1990;
Rubin, 1990).
Different inductive agents produce the same kind of lesion.
For example, chemical carcinogens, human papillomaviruses,
and ultraviolet light all produce squamous papillomas as the
initial lesion.
Failure of the initial lesion to disappear, commonly follow-
ed by an aberrant growth pattern within the initial lesion, is
a cardinal step in tumour progression that may lead to overt
cancer. Conversely, if the initial lesion follows its pathway of
differentiation and disappearance cancer does not develop.
The various lesions with temporally restricted growth that
may precede cancer are precursor lesions and are the Class I
lesions of tumour progression.
Late Class I lesions (Class IC) contain many structurally
atypical cells, cells similar in appearance to some cells
appearing in invasive, primary cancers. These cells appear
prior to biological cancer and may be the main source of the
next lesional class.
The sequential lesions leading to the development of a
primary cancer are the result of focal, not global, changes
within a lesion.
Autonomous growth (temporally unrestricted growth) is
the lesional property that distinguishes the later lesions ofTUMOUR PROGRESSION AND THE NATURE OF CANCER 641
tumour progression from Class I lesions. This property is
neither usually nor necessarily accompanied by capacity for
metastasis. In fact, even the capacity for invasion is absent
or quite limited. Lesions showing temporally unrestricted
growth, but few other attributes of a completely evolved
cancer, are Class II lesions.
Class III lesions are primary cancers: lesions showing tem-
porally unrestricted growth, the ability to grow in the mesen-
chyme of the primary site and some ability to metastasise.
Those Class III lesions with the ability to metastasise are
fully evolved primary cancers.
Metastases are Class IV lesions. There are diverse metas-
tatic pathways that may reflect subpopulations of cells in a
primary cancer with properties required for completion of
one metastatic pathway and not, necessarily, another.
The various classes of tumour progression lesions are
clearly manifest in human, cutaneous melanocytic neoplasia.
Keratinocytic, hepatic, and colonic neoplasia have been com-
pared with melanocytic neoplasia and their development is
similar.
Cancer, like time, presents no problem in definition until
one is asked to define it. However, one cannot observe cancer
and lesions related to its development over and over again
without attempting to define it. In such an attempt one is
forced, in the words of Garth Nicolson, '... into grandiose
hypotheses that might explain the complex dynamic nature of
cancers .. .' (Nicolson, 1987). In the same article, Nicholson
warns us, quoting Vriel, that 'no unitary concept can give a
satisfactory explanation of the initimate nature of cancer'. I
should leave the matter of the nature of cancer with Nicol-
son's warning, but already having indulged in 'grandiose
hypotheses' and such things as cardinal properties, I must list
the events that I regard as fundamental to the development
of cancer and the development of metastasis. The concepts
are not unitary, but pluralistic.
(1) The precursor states
Cancers develop from precursor conditions that may result in
large numbers of atypical cells. Farber has suggested that the
initial lesions of neoplastic development (the hepatocyte
nodule in hepatocarcinogenesis) are a physiologic response to
cellular injury and are protective to the organism; the failure
of the initial lesions to differentiate and disappear is the first
indication that a pathway toward the development of cellular
atypia has been evoked (Farber & Sarma, 1987). Aberrent
growth and the apparance of atypical cells (dysplastic lesions)
usually accompany the failure to differentiate: the pathway to
cancer has begun. Yuspa has suggested that the process of
carcinogenesis requires an alteration in the program of ter-
minal differentiation in addition to aberrent growth control
(Yuspa et al., 1988). Evidence from the study of different
neoplastic sysems suggests that this alteration of different-
iation occurs as a flaw in the usual behaviour of initial
lesions. Atypical cells similar to those of classical dysplastic
lesions may develop without such lesions being manifest,
possibly as a result of a concatenation of events occurring in
single cells. The precursor conditions with their population of
atypical cells are a necessary state for cancer to develop.
(2) Clonal transformation
A lesion (an intermediate lesion) showing temporally unre-
stricted growth is the forerunner of cancer. It is posited that
the intermediate lesions are the result of the clonal transfor-
mation of one of the atypical cells of the precursor state. The
term transformation is borrowed from its in vitro usage and
dose not imply tumourigenecity (Stanbridge et al., 1982).
These lesions may be regarded as the very beginnings of
cancer and are usually termed 'in situ malignancy'. They
develop in one of many precursor sites, in one of many
individuals affected by the precursor conditions of a neoplas-
tic system. Most precursor lesions and conditions are end
stage lesions with no future.
(3) Acquisition ofmetastatic competence and tumour cell
heterogeneity by reciprocal interaction with the extracellular
matrix
Intermediate lesions show a tendency to persist and progress
rather than to regress and become indolent. Growth and
progression commonly lead to extension beyond the tissue
compartment of origin and, in due course, to diminished
synthesis of an intact basement membrane zone. With partial
disappearance of the basement membrane zone, tumour cells
interact with the nonbasement membrane extracellular mat-
rix. It should be remembered, with regard to tumour cell-
extracellular matrix interaction, that the tumour cells are
abnormal. Consequently, the neoplastic parenchyma may be
expected to invoke abnormalities in the extracellular matrix
and the abnormal matrix to induce further abnormalities in
the tumour cells; again and again, reciprocally. There could
well be a conflation of genetic and nongenetic sources of
information responsible for lesional behaviour in vertical
growth phase melanomas (and its analogies) and in metas-
tasis. Such reciprocal interaction is similar to that proposed
and discussed by Mina Bissell (Bissell et al., 1982). The cells
of the tumour may then express an environmentally depen-
dent (extracellular matrix) form ofcellular inheritance. Harry
Rubin considers such changes in tumours as one form of
epigenesis, 'the acquisition ofheritable characteristics without
a covalent change in cellular DNA' (Rubin, 1990). Such
heritable characteristics would not be stable, but dynamic
due to a continuum of interation with the extracellular mat-
rix (Rubin et al., 1985). Vriel is doubtless correct in stating
that no unitary concept can explain the 'intimate nature' of
cancer. There is no oncogene, tumour suppressor gene, or
chromosomal abnormality that is present routinely in cancer.
In fact, some cancers have no demonstrable abnormalities of
oncogenes or tumour suppressor genes and some are strictly
diploid (Nicolson, 1987). Further, initial lesions, the response
to carcinogens, are usually composed ofdiploid cells and the
individual cells of initial lesions appear normal. Yet, and this
is the main thrust of this paper, all neoplasms develop in the
same way, have the same general behavioural characteristics
and, when malignant, they all interact with the extracellular
matrix of the primary and the secondary sites. They are
unitary only in their developmental history and interaction
with the extracellular matrix. Continued interaction with the
extracellular matrix could be a form of natural selection.
Such interaction with the matrix selects subsets of cells with
heritable genetic and heritable epigenetic characteristics that
use specific metastatic pathways. Late in the evolution of
primary tumours, cells with metastatic competence may come
to dominate the primary cancer (Kerbel et al., 1988).
(4) Distant metastases as a continuum ofreciprocal
interaction with an extracellular matrix
Metastases to distant organs are characterised by a continua-
tion of reciprocal interaction with an extracellular matrix and
adaptation to the specific matrix of that site. Except for
lymph node metastases, a metastatic deposit is always in a
mesenchyme. The last step in tumour progression is complete
loss of influence of the microenvironment on the tumour
(Nicolson, 1987). Such a last step is probably quite rare.
A list of the events and properties of a complete neoplastic
system would be almost endless and similar in magnitude to
the events of embryogenesis. There is not enough DNA nor
abnormalities of DNA to explain neoplasia. That which is
abnormal is not consistent from one neoplasm to the next.
The magnitude of the problem is clearly expressed by R.C.
Lewontin in his review of Edelman's book on Topobiology. I
quote Lewontin, 'The problem is not one of dimension but of
size. The nucleus of the cell of the fruit fly Drosophila, the
favourite organism of the ge.neticists has enough DNA to
specify the structure of about 5,000 different proteins and
about 30 times that much DNA is available to provide
spatial and temporal instructions about when the production
of proteins by those genes should be turned on and turned642 W.H. CLARK
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Figure 4 The pattern of normal nevi in a 22 year old woman is shown. The appearance is characteristic of the initial lesions of
melanocytic neoplasia (Class IA lesion). The nevi are small and relatively uniform in colour and outline. The lesions usually
differentiate and disappear over the next three decades of life. Figure 5 The clinical presentation ofmelanocytic nevi with aberrant
differentiation and dysplasia in a 30 year old male patient who developed melanoma. The lesions are prototypic for Class IB and
IC lesions ofmelanocytic neoplasia and manifest the beginning of tumour progression. Representative lesions are larger and more
irregular in outline and colouration than normal nevi (Class IA). Figures 6 and 7 The development ofdysplastic nevi over a 6 year
period in a male patient is shown. The patient's grandmother had melanoma and his father has dysplastic nevi. Figure 6 was taken
at age 7 and Figure 7 at age 13. Class IB and IC lesions (aberrant differentiation and dysplasia) tend to slowly enlarge and thenTUMOUR PROGRESSION AND THE NATURE OF CANCER 643
become indolent. Differentiation and disappearance is uncommon. Figure 8 The photograph illustrates a malignant melanoma in
the radial growth phase (Class IIB lesion) arising from a dysplastic nevus. The dysplastic nevus is the upper, irregular, tan-brown
part of the lesion. The melanoma is the lower, black area. Class IIB lesions extend into the subjacent mesenchyme but do not
metastasise. The cells in the dermis of radial growth phase melanomas usually show individual cells or small nests of cells
surrounded by an intact basement membrane zone. Figure 9 A malignant melanoma that has-evolved from the radial to the
vertical growth phase is shown. The picture is representative of a melanoma that has progressed to metastatic competence as
manifested by the ability to grow in the mesenchyme of the primary site (Class III lesion). The upper centre and right portion of
the photograph illustrate the radial growth phase. The centre shows an area of regression. The black nodule on the left is the
vertifical growth phase partially surrounded by a remnant of a dysplastic nevus.
off. But this is simply too little, by many orders of magni-
tude, to tell every cell when it should divide, exactly where it
should move next, and what cellular structures it should
produce, over the entire developmental history ofthe fly. One
needs to imagine an instruction manual that will tell every
New Yorker when to wake up, where to go, and what to do,
hour by hour, day by day, for the next century. There is just
not enough DNA to go around' (Lewontin, 1989). To ex-
plain metazoan life or explain neoplasia in metazoan life.
Finally, it must be stated that tumour progression is not
some engima hidden in the jargon of pathologists or mole-
cular biologists. The lesions are not only visible, but their
very appearance attests to their behaviour and, thus, to some
aspect of their nature. The symmetry, differentiation and
disappearance of initial lesions may be observed. The abnor-
malcy of aberrant differentiation is manifest as a large,
asymmetrical nevus. The temporally unrestricted growth of
intermediate lesions may be historically confirmed. Acquisi-
tion of competence for metastasis is reflected in changes in
form of the primary cancer. All of the events of tumour
progression are exceedingly complicated at the molecular
level; at the level of the cell and the organism, however,
tumour progression can be visualised and conceptualised.
The accompanying illustrations permit one to visualise the
sequence of lesional tumour progression events in human
melanocytic neoplasia (Figures 4-9).
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